Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Mol Med (Berl) ; 89(10): 1015-26, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21607540

ABSTRACT

Atherosclerotic carotid stenosis is an important risk factor for stroke. Carotid plaques (CPs) causing stroke may present a distinct type of molecular pathology compared with transient ischemic attack (TIA)-associated or asymptomatic plaques. We compared the gene expression profiles of CPs from stroke patients (n = 12) and asymptomatic patients (n = 9), both with similar risk factors and severity of carotid stenosis (>70%). Sixty probes showed over 1.5-fold expression difference at 5% false discovery rate. Functional clustering showed enrichment of genes in 51 GO categories and seven pathways, the most significant of which relate to extracellular-matrix interaction, PPAR gamma signaling, scavanger receptor activity, and lysosomal activity. Differential expression of ten genes was confirmed in an extended replication group (n = 43), where the most significant expression differences were found in CD36 (2.1-fold change, p = 0.005), CD163 (1.7-fold change, p = 0.007) and FABP4 (2.2-fold change, p = 0.015). These include four genes not previously linked to plaque destabilization: GLUL (2.2-fold change, p = 0.016), FUCA1 (2.2-fold change, p = 0.025), IL1RN (1.6-fold change, p = 0.034), and S100A8 (2.5-fold change, p = 0.047). Strong correlations were found to plaque ulceration, plaque hemorrhage, and markers of apoptosis and proliferation (activated caspase 3, TUNEL, and Ki67). Protein expression of these genes was confirmed by immunohistochemistry and was found in the atheromatous areas of CPs critical for plaque destabilization. This study presents a comprehensive transcriptional analysis of stroke-associated CPs and demonstrates a significant transcriptome difference between stroke-associated and asymptomatic CPs. Follow-up studies on the identified genes are needed to define whether they could be used as biomarkers of symptomatic CPs or have a role in plaque destabilization.


Subject(s)
Carotid Stenosis/complications , Carotid Stenosis/genetics , Gene Expression Profiling , Stroke/complications , Stroke/genetics , Aged , Carotid Stenosis/pathology , Cluster Analysis , DNA Probes/metabolism , Female , Gene Expression Regulation , Humans , Immunohistochemistry , Male , Middle Aged , Oligonucleotide Array Sequence Analysis , Reproducibility of Results , Stroke/pathology
2.
Stroke ; 38(6): 1791-8, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17446422

ABSTRACT

BACKGROUND AND PURPOSE: Adipophilin is an adipose differentiation-related protein expressed in lipid-containing cells. Using DNA microarray analysis, we previously found the adipophilin gene (ADFP) to be overexpressed in symptomatic carotid plaques (CP). This led us to further examine the role of adipophilin in carotid atherosclerosis relative to symptom status. METHODS: Ninety-eight high-grade (>70%) CPs were obtained in carotid endarterectomy. The relative expression of ADFP mRNA was measured by quantitative real-time RT-PCR, and the relative amount of adipophilin protein was quantified with Western blotting. Detailed topographical correlations with extravasated red blood cells and extracellular cholesterol crystals were obtained by means of immunohistochemistry. RESULTS: The relative expression of ADFP mRNA was increased in symptomatic compared with asymptomatic CPs at both the mRNA level (1.82+/-0.19[SE] versus 1.25+/-0.15, P=0.012) and the protein level (1.04+/-0.23 versus 0.46+/-0.14, P=0.043). Adipophilin colocalized with macrophage foam cells, extravasated red blood cells (P<0.0001), and cholesterol crystals (P<0.0001), and its expression associated with macroscopic ulceration of CP (P<0.0001). CONCLUSIONS: Intraplaque hemorrhages may contribute to intracellular lipid accumulation and consequent adipophilin expression. Because adipophilin blocks cholesterol efflux from lipid-laden cells, they may die and develop a necrotic lipid core, thereby destabilizing the plaque.


Subject(s)
Carotid Artery Diseases/metabolism , Carotid Artery Diseases/pathology , Carotid Artery, Internal/metabolism , Cholesterol/metabolism , Erythrocytes/metabolism , Gene Expression Regulation/physiology , Peptides/metabolism , Aged , Carotid Artery Diseases/genetics , Carotid Artery, Internal/pathology , Cholesterol/analysis , Crystallization , Female , Humans , Male , Membrane Proteins , Middle Aged , Necrosis , Peptides/genetics , Perilipin-2
3.
Restor Neurol Neurosci ; 24(1): 17-23, 2006.
Article in English | MEDLINE | ID: mdl-16518024

ABSTRACT

PURPOSE: Enriched environment housing enhances brain plasticity and improves recovery of impaired sensorimotor and cognitive functions of rats subjected to transient middle cerebral artery occlusion (MCAO). The present study applied microarray technique to investigate the molecular basis through which enriched environment might improve spatial learning in MCAO rats. METHODS: MCAO rats were housed in enriched environment or in standard single cages, and sham-operated rats were housed in standard single cages. Spatial learning was assessed using the Morris water-maze on postoperative days 22 to 24. Total RNA from the ipsilateral hippocampus was extracted for microarray analysis after the follow-up period. RESULTS: Water-maze performance on postoperative days 22 to 24 showed that rats subjected to transient MCAO were impaired in the hippocampus-dependent Morris water-maze test. Enriched environment housing reversed the spatial learning impairment on postoperative day 23. Gene expression in the hippocampus was not affected by MCAO or following enriched environment housing. CONCLUSION: Spatial learning impairment following transient MCAO in rats and cognitive improvement following housing in enriched environment is not related to % related to extrahippocampal brain regions rather than altered hippocampal gene expression.


Subject(s)
Brain Ischemia/genetics , Brain Ischemia/rehabilitation , Environment , Gene Expression Profiling , Gene Expression/physiology , Hippocampus/physiopathology , Animals , Brain Ischemia/pathology , Confidence Intervals , Disease Models, Animal , Hippocampus/pathology , Male , Maze Learning/physiology , Microarray Analysis/methods , Odds Ratio , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL